Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. (Q34658204)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37621503)
(P275) (Q15643954)
(P304) 2203-2204
(P407) (Q1860)
(P433) 11
(P478) 111
(P577) Tuesday, August 12, 2014
(P1433) (Q326309)
(P1476) "Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer" (language: en)
(P2093) A Choughule
R Sharma
V Trivedi
A Thavamani
V Noronha
A Joshi
S Desai
P Chandrani
P Sundaram
S Utture
N Jambhekar
S Gupta
J Aich
K Prabhash
(P2860) (Q33682941)
(Q35016912)
(Q34688967)
(Q27851703)
(Q37797818)
(Q39213209)
(Q27860881)
(Q27824867)
(Q28301684)
(Q29615475)
(Q34555510)
(Q21563446)
(Q45190258)
(Q27824812)
(Q27861059)
(Q46484712)
(Q42997609)
(Q57908992)
(P6216) (Q50423863)